- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Pharma Equity Group AS (PEGRP)
Pharma Equity Group AS stock price live, this page displays CSE PEGRP stock exchange data. View the PEGRP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Pharma Equity Group AS real time stock price chart below.
What Is the Pharma Equity Group AS Stock Price Today?
The Pharma Equity Group AS stock price today is 0.085.
What Is the Stock Symbol for Pharma Equity Group AS?
The stock ticker symbol for Pharma Equity Group AS is PEGRP.
Is PEGRP the Same as $PEGRP?
$PEGRP is a common way to refer to the Pharma Equity Group AS ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Pharma Equity Group AS Trade On?
Pharma Equity Group AS is listed and trades on the Copenhagen stock exchange.
Is Pharma Equity Group AS a Good Stock to Buy?
Determining whether Pharma Equity Group AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Pharma Equity Group AS share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PEGRP quote. (ISIN: DK0061155009)
What Is the Pharma Equity Group AS Stock Price Today?
The Pharma Equity Group AS stock price today is 0.085.
What Is the Stock Symbol for Pharma Equity Group AS?
The stock ticker symbol for Pharma Equity Group AS is PEGRP.
Is PEGRP the Same as $PEGRP?
$PEGRP is a common way to refer to the Pharma Equity Group AS ticker symbol in social media, forums, and online discussions. The dollar sign is a shorthand convention used to indicate that it is a stock ticker symbol
What Stock Exchange Does Pharma Equity Group AS Trade On?
Pharma Equity Group AS is listed and trades on the Copenhagen stock exchange.
Is Pharma Equity Group AS a Good Stock to Buy?
Determining whether Pharma Equity Group AS—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess the current Pharma Equity Group AS share price compared with the fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the PEGRP quote. (ISIN: DK0061155009)
Copenhagen
Currency in DKK
0.085
0.000(0.00%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.082
0.089
52 wk Range
0.073
0.150
Earnings results expected in 13 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.0820.089
52 wk Range
0.0730.150
Key Statistics
Edit
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Vol. (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
PEGRP Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Liquid assets exceed short term obligations
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Earnings
Latest Release
Mar 18, 2026
EPS / Forecast
-0.01 / 0.02
Revenue / Forecast
-- / 25M
Compare PEGRP to Peers and Sector
Metrics to compare | PEGRP | Sector Sector - Average of metrics from a broad group of related Financials sector companies | Relationship RelationshipPEGRPPeersSector | |
|---|---|---|---|---|
P/E Ratio | −4.1x | −0.7x | −0.5x | |
PEG Ratio | −0.09 | 0.17 | 0.00 | |
Price / Book | 4.1x | 1.4x | 2.6x | |
Price / LTM Sales | - | 0.7x | 3.2x | |
Upside (Analyst Target) | - | 85.4% | 50.8% | |
Fair Value Upside | Unlock | −4.8% | 7.7% | Unlock |
Pharma Equity Group A/S, through its subsidiary, Reponex Pharmaceuticals A/S, a clinical-stage biopharmaceutical company, develops treatments for diseases that have patient and social impact for which the current therapy is lacking or in need of improvement. Its products under development, includes RNX-011 for the treatment of bacterial peritonitis; RNX-021, RNX-022, and RNX-023 for the treatment of chronic skin ulcers; RNX-041 for the treatment of inflammatory bowel diseases, such as chrons and pouchitis; and RNX-051 for the treatment of colorectal cancer and colon adenoma that are in Phase II clinical trials. The company was incorporated in 2002 and is headquartered in Horsholm, Denmark.
FAQ
What Is the Pharma Equity AS (PEGRP) Stock Price Today?
The Pharma Equity AS stock price today is 0.085 DKK.
What Stock Exchange Does Pharma Equity AS Trade On?
Pharma Equity AS is listed and trades on the Copenhagen Stock Exchange.
What Is the Stock Symbol for Pharma Equity AS?
The stock symbol for Pharma Equity AS is "PEGRP."
What Is the Pharma Equity AS Market Cap?
As of today, Pharma Equity AS market cap is 104.590M DKK.
What Is Pharma Equity AS's Earnings Per Share (TTM)?
The Pharma Equity AS EPS (TTM) is -0.021.
When Is the Next Pharma Equity AS Earnings Date?
Pharma Equity AS will release its next earnings report on May 14, 2026.
From a Technical Analysis Perspective, Is PEGRP a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Pharma Equity AS Stock Split?
Pharma Equity AS has split 5 times.
How Many Employees Does Pharma Equity AS Have?
Pharma Equity AS has 5 employees.
What is the current trading status of Pharma Equity AS (PEGRP)?
As of May 01, 2026, Pharma Equity AS (PEGRP) is trading at a price of 0.085 DKK, with a previous close of 0.085 DKK. The stock has fluctuated within a day range of 0.082 DKK to 0.089 DKK, while its 52-week range spans from 0.073 DKK to 0.150 DKK.
Industry Spotlight
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.